Spots Global Cancer Trial Database for Optimal Prophylactic Method of Venous Thromboembolism (VTE)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Official Title: Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients

Study ID: NCT01448746

Conditions

Venous Thromboembolism

Interventions

low molecular weight heparin

Study Description

Brief Summary: This study is to define the optimal method of prophylaxis for patients with gastrectomy in Korea and the investigators hypothesized only mechanical method would be enough for preventing VTE on perioperative period.

Detailed Description: Venous thromboembolism (VTE) is common and often fatal complication in patients with cancer. Gastric cancer is the most frequent cancer in Korea. The incidence of VTE would be increased in patients with gastric cancer, especially associated surgery. However, the incidence and optimal prophylactic method associated with cancer surgery are not well studied in Asian patients. Most Korean surgeon concerns regarding the increased postoperative bleeding associated with low molecular weight heparin(LMWH)prophylaxis. The incidence and adverse event will be examined to define the optimal prophylactic method of VTE in surgical patients with gastric cancer.